anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Treatment of periodontitis for glycaemic control in people with diabetes mellitus
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Periodontitis 5. Young Adult 19-24 years 6. Diabetes Mellitus 7. Aged 65-79 years
Provide patient population that should be included in the study
Interventions for treating cavitated or dentine carious lesions
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Dental Caries Extending Into Dentine 4. Adult 19-44 years 5. Child 6-12 years 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Laser therapy for dentinal hypersensitivity
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Child 6-12 years 4. Sensitive Dentin 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for replacing missing teeth: alveolar ridge preservation techniques for dental implant site development
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Loss Of Teeth Due To Extraction 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Adjunctive systemic antimicrobials for the non‐surgical treatment of periodontitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Periodontitis 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for treating oral lichen planus: corticosteroid therapies
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Oral Lichen Planus 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for increasing acceptance of local anaesthetic in children and adolescents having dental treatment
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Local Anesthetics 5. Birth to 1 mo 6. Dental procedures 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral hygiene interventions for people with intellectual disabilities
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Intellectual Disability 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotic use for irreversible pulpitis
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Irreversible Pulpitis 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Routine scale and polish for periodontal health in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years
Provide patient population that should be included in the study
Home‐based chemically‐induced whitening (bleaching) of teeth in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Staining Of Tooth 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Atraumatic restorative treatment versus conventional restorative treatment for managing dental caries
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Dental Caries Extending Into Dentine 4. Adult 19-44 years 5. Child 6-12 years 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Metal‐free materials for fixed prosthodontic restorations
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Tooth Loss 4. Middle Aged 45-64 years 5. Tooth Surface Loss 6. Young Adult 19-24 years 7. Aged 65-79 years
Provide patient population that should be included in the study
Pharmacological interventions for pain relief during orthodontic treatment
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Orthodontic Appliance Wearer 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Fluoride supplementation (with tablets, drops, lozenges or chewing gum) in pregnant women for preventing dental caries in the primary teeth of their children
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Resorbable versus titanium plates for orthognathic surgery
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Surgery 5. Young Adult 19-24 years 6. Dentofacial Anomaly 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Open versus closed surgical exposure of canine teeth that are displaced in the roof of the mouth
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Impacted Permanent Canine Tooth 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Pit and fissure sealants for preventing dental decay in permanent teeth
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Young Adult 19-24 years 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Chlorhexidine mouthrinse as an adjunctive treatment for gingival health
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Periodontitis 7. Young Adult 19-24 years 8. Gingivitis 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐pharmacological interventions for alleviating pain during orthodontic treatment
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Orthodontic Appliance Wearer 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Adhesives for fixed orthodontic bands
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Orthodontic Appliance Wearer 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Endodontic procedures for retreatment of periapical lesions
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Disorder Of Pulp Of Tooth 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Sleep Apnea 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral health education (advice and training) for people with serious mental illness
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Severe mental disorder 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Preoperative analgesics for additional pain relief in children and adolescents having dental treatment
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Dental procedures 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Fluoride mouthrinses for preventing dental caries in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Adolescent 13-18 years
Provide patient population that should be included in the study
Infraorbital nerve block for postoperative pain following cleft lip repair in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Postoperative Pain 4. Infant 1 to 23 mo 5. Repair Of Cleft Lip
Provide patient population that should be included in the study
Preformed crowns for decayed primary molar teeth
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Dental Caries 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Mucositis Oral 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Cancer
Provide patient population that should be included in the study
Interventions for treating traumatised ankylosed permanent front teeth
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Ankylosis Of Tooth 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Magnification devices for endodontic therapy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Disorder Of Pulp Of Tooth 7. Young Adult 19-24 years 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for the management of external root resorption
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Child 6-12 years 4. External Non-apical Resorption Of Root Of Tooth 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Micro‐invasive interventions for managing proximal dental decay in primary and permanent teeth
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Dental Caries Extending Into Dentine 4. Adult 19-44 years 5. Child 6-12 years 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Aged 65-79 years 10. Enamel Caries 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Salivary gland dysfunction 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Sedation versus general anaesthesia for provision of dental treatment to patients younger than 18 years
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Dental procedures 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Single crowns versus conventional fillings for the restoration of root‐filled teeth
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Disorder Of Pulp Of Tooth 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Fluoridated milk for preventing dental caries
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Fluoride gels for preventing dental caries in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Adolescent 13-18 years
Provide patient population that should be included in the study
Chlorhexidine treatment for the prevention of dental caries in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for the cessation of non‐nutritive sucking habits in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Digit Sucking 4. Infant 1 to 23 mo 5. Pacifier Sucking 6. Birth to 1 mo 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Intraoperative local anaesthesia for reduction of postoperative pain following general anaesthesia for dental treatment in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Dental procedures 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Powered versus manual toothbrushing for oral health
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Oral Hygiene 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Triclosan/copolymer containing toothpastes for oral health
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Enamel etching for bonding fixed orthodontic braces
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Orthodontic Appliance Wearer 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for replacing missing teeth: antibiotics at dental implant placement to prevent complications
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Prosthetic Dental Implant 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Fluoride varnishes for preventing dental caries in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychosocial interventions for survivors of rape and sexual assault experienced during adulthood
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Sexual Assault Victim 6. Victim Of Rape 7. Aged 65-79 years
Provide patient population that should be included in the study
Interventions from pregnancy to two years after birth for parents experiencing complex post‐traumatic stress disorder and/or with childhood experience of maltreatment
1. Childhood maltreatment 2. Parent 3. Complex Post-traumatic Stress Disorder
Provide patient population that should be included in the study
Crisis interventions for adults with borderline personality disorder
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Borderline Personality Disorder 6. Aged 65-79 years
Provide patient population that should be included in the study
Medications for daytime sleepiness in individuals with idiopathic hypersomnia
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Idiopathic Hypersomnia 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Attention Deficit Hyperactivity Disorder 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychological interventions to foster resilience in healthcare students
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Healthcare Professional 4. Young Adult 19-24 years 5. Student
Provide patient population that should be included in the study
Speech and language therapy for management of chronic cough
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Chronic Cough 6. Middle Aged 45-64 years 7. Unexplained Cough 8. Infant 1 to 23 mo 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Attention Deficit Hyperactivity Disorder 4. Young Adult 19-24 years
Provide patient population that should be included in the study
De‐escalation techniques for managing non‐psychosis induced aggression in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Aggressive Behavior 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antidepressants for insomnia in adults
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Insomnia 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Attention Deficit Hyperactivity Disorder 5. Young Adult 19-24 years 6. Hyperkinetic Conduct Disorder 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Point‐of‐use fortification of foods with micronutrient powders containing iron in children of preschool and school‐age
1. Child, Preschool 2-5 years 2. Child 6-12 years
Provide patient population that should be included in the study
Methylphenidate for children and adolescents with autism spectrum disorder
1. Child 6-12 years 2. Autism Spectrum Disorder 3. Adolescent 13-18 years
Provide patient population that should be included in the study
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Attention Deficit Hyperactivity Disorder 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Atypical antipsychotics for disruptive behaviour disorders in children and youths
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo
Provide patient population that should be included in the study
Task‐oriented interventions for children with developmental co‐ordination disorder
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Dyspraxia 4. Developmental Coordination Disorder 5. Clumsy 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Treadmill interventions in children under six years of age at risk of neuromotor delay
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo 3. Gross Motor Development Delay 4. Neurodevelopmental Delay
Provide patient population that should be included in the study
Exercise interventions for cerebral palsy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Cerebral Palsy 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Family therapy for autism spectrum disorders
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Autism Spectrum Disorder 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Dietary interventions for recurrent abdominal pain in childhood
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Functional Abdominal Pain Syndrome 4. Functional Abdominal Pain 5. Irritable bowel syndrome 6. Abdominal Migraine 7. Nonulcer Dyspepsia 8. Recurrent Abdominal Pain 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychosocial interventions for recurrent abdominal pain in childhood
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Functional Abdominal Pain Syndrome 4. Irritable bowel syndrome 5. Functional Abdominal Pain 6. Abdominal Migraine 7. Nonulcer Dyspepsia 8. Recurrent Abdominal Pain 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Group‐based parent training programmes for improving emotional and behavioural adjustment in young children
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Parent 5. Young Adult 19-24 years 6. Caregiver 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Aripiprazole for autism spectrum disorders (ASD)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Autism Spectrum Disorder 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Attention Deficit Hyperactivity Disorder 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Advocacy interventions to reduce or eliminate violence and promote the physical and psychosocial well‐being of women who experience intimate partner abuse
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Victim Of Domestic Violence 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Intrathecal baclofen for treating spasticity in children with cerebral palsy
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Adolescent 13-18 years 6. Spastic Cerebral Palsy
Provide patient population that should be included in the study
Sleep positioning systems for children with cerebral palsy
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Cerebral Palsy 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmacological interventions for cognitive decline in people with Down syndrome
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Down syndrome 6. Aged 65-79 years
Provide patient population that should be included in the study
Clozapine for psychotic disorders in adults with intellectual disabilities
1. Aged 80 and over 80+ years 2. Psychosis 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Intellectual Disability 7. Aged 65-79 years
Provide patient population that should be included in the study
Screening women for intimate partner violence in healthcare settings
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Healthcare services 5. Intimate Partner Violence 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Screening Procedure
Provide patient population that should be included in the study
Non‐speech oral motor treatment for children with developmental speech sound disorders
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Developmental speech disorder 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Food supplementation for improving the physical and psychosocial health of socio‐economically disadvantaged children aged three months to five years
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo 3. Economic Problem
Provide patient population that should be included in the study
Pharmacological interventions for those who have sexually offended or are at risk of offending
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Sexual Offending Behavior 6. Aged 65-79 years
Provide patient population that should be included in the study
Parent‐infant psychotherapy for improving parental and infant mental health
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Domestic Abuse 5. Young Adult 19-24 years 6. Mental state 7. Substance Abuse 8. Aged 65-79 years
Provide patient population that should be included in the study
Centre‐based day care for children younger than five years of age in low‐ and middle‐income countries
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo 3. Birth to 1 mo
Provide patient population that should be included in the study
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents
1. Child 6-12 years 2. Attention Deficit Hyperactivity Disorder 3. Adolescent 13-18 years
Provide patient population that should be included in the study
The WHO Health Promoting School framework for improving the health and well‐being of students and their academic achievement
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Student 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions based on the Theory of Mind cognitive model for autism spectrum disorder (ASD)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Autism Spectrum Disorder 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Auditory‐verbal therapy for promoting spoken language development in children with permanent hearing impairments
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Bilateral Hearing Loss 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Kinship care for the safety, permanency, and well‐being of children removed from the home for maltreatment
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Foster Care 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Fundoplication versus postoperative medication for gastro‐oesophageal reflux in children with neurological impairment undergoing gastrostomy
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Gastrostomy Tube Insertion 4. Neurological Impairment 5. Gastroesophageal Reflux Disease 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Gastrostomy feeding versus oral feeding alone for children with cerebral palsy
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Feeding Problem 4. Cerebral Palsy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Adolescent 13-18 years 4. Victim Of Child Sexual Abuse
Provide patient population that should be included in the study
Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo 3. Malnutrition 4. Nutritional Wasting
Provide patient population that should be included in the study
Specialist home‐based nursing services for children with acute and chronic illnesses
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Acute Disease 4. Infant 1 to 23 mo 5. Birth to 1 mo 6. Chronic Disease 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Parent‐mediated early intervention for young children with autism spectrum disorders (ASD)
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Autism Spectrum Disorder
Provide patient population that should be included in the study
Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects
1. Assisted reproductive techniques
Provide patient population that should be included in the study
Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Tuberculosis 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Adenoidectomy for otitis media with effusion (OME) in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Otitis Media with Effusion 4. Infant 1 to 23 mo
Provide patient population that should be included in the study
Pharmacological interventions for prophylaxis of vestibular migraine
1. Vestibular migraine
Provide patient population that should be included in the study
Pharmacological interventions for acute attacks of vestibular migraine
1. Vestibular migraine
Provide patient population that should be included in the study
Non‐pharmacological interventions for prophylaxis of vestibular migraine
1. Vestibular migraine
Provide patient population that should be included in the study
Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD)
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Persistent postural-perceptual dizziness 6. Aged 65-79 years
Provide patient population that should be included in the study
Intratympanic corticosteroids for Ménière’s disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Meniere's Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Intratympanic gentamicin for Ménière’s disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Meniere's Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Lifestyle and dietary interventions for Ménière’s disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Meniere's Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Surgical interventions for Ménière’s disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Meniere's Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Systemic pharmacological interventions for Ménière’s disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Meniere's Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Positive pressure therapy for Ménière’s disease
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Meniere's Disease 6. Aged 65-79 years
Provide patient population that should be included in the study
Tranexamic acid for the reduction of bleeding during functional endoscopic sinus surgery
1. Child, Preschool 2-5 years 2. Nasal Sinus Endoscopy 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Chronic Rhinosinusitis 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Antihistamines for motion sickness
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction
1. Aged 80 and over 80+ years 2. COVID-19 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Anosmia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction
1. Aged 80 and over 80+ years 2. COVID-19 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Anosmia 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Intratympanic corticosteroids for sudden sensorineural hearing loss
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Sudden Sensorineural Hearing Loss 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Medical interventions for chronic rhinosinusitis in cystic fibrosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Cystic Fibrosis 8. Young Adult 19-24 years 9. Chronic Rhinosinusitis 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Biologics for chronic rhinosinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Nasal Polyp 8. Young Adult 19-24 years 9. Chronic Rhinosinusitis 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Sore Throat 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Cognitive behavioural therapy for tinnitus
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Tinnitus 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Tranexamic acid for patients with nasal haemorrhage (epistaxis)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Epistaxis 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Sound therapy (using amplification devices and/or sound generators) for tinnitus
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Tinnitus 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotics for acute rhinosinusitis in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Aged 65-79 years 6. Acute Rhinosinusitis
Provide patient population that should be included in the study
Perioperative local anaesthesia for reducing pain following septal surgery
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Operation On Nasal Turbinate 7. Infant 1 to 23 mo 8. Operation On Nasal Septum 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Bilateral versus unilateral hearing aids for bilateral hearing impairment in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Bilateral Hearing Loss 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Influenza vaccines for preventing acute otitis media in infants and children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Hearing aids for mild to moderate hearing loss in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Hearing impairment 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Heated, humidified air for the common cold
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Common Cold 10. Aged 65-79 years 11. Parainfluenza Virus Rhinopharyngitis 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Coblation versus other surgical techniques for tonsillectomy
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Tonsillectomy 6. Young Adult 19-24 years 7. Ventilation Tube In Tympanic Membrane 8. Tonsillectomy & Adenoidectomy 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Needle aspiration versus incision and drainage for the treatment of peritonsillar abscess
1. Adult 19-44 years 2. Child 6-12 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years 6. Peritonsillar Abscess
Provide patient population that should be included in the study
Interventions for children with ear discharge occurring at least two weeks following grommet (ventilation tube) insertion
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Ventilation Tube In Tympanic Membrane 6. Adolescent 13-18 years 7. Otorrhea
Provide patient population that should be included in the study
Nasal decongestants in monotherapy for the common cold
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Upper Respiratory Infection 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Common Cold 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions to improve hearing aid use in adult auditory rehabilitation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Hearing impairment 5. Young Adult 19-24 years 6. Hearing Aid Wearer 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Betahistine for symptoms of vertigo
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Vertigo 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotics for otitis media with effusion in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Otitis Media with Effusion 4. Infant 1 to 23 mo 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Chronic Rhinosinusitis 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Different types of intranasal steroids for chronic rhinosinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Chronic Rhinosinusitis 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Polyps Nasal
Provide patient population that should be included in the study
Saline irrigation for chronic rhinosinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Chronic Rhinosinusitis 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Polyps Nasal
Provide patient population that should be included in the study
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Chronic Rhinosinusitis 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Polyps Nasal
Provide patient population that should be included in the study
Short‐course oral steroids alone for chronic rhinosinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Nasal Polyp 8. Young Adult 19-24 years 9. Chronic Rhinosinusitis 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Systemic and topical antibiotics for chronic rhinosinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Chronic Rhinosinusitis 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Water precautions for prevention of infection in children with ventilation tubes (grommets)
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Otitis Media with Effusion 4. Infant 1 to 23 mo 5. Birth to 1 mo 6. Ventilation Tube In Tympanic Membrane 7. Adolescent 13-18 years 8. Recurrent Acute Otitis Media
Provide patient population that should be included in the study
Antihistamines for the common cold
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Common Cold 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Corticosteroids for the common cold
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Common Cold 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Non‐steroidal anti‐inflammatory drugs for the common cold
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Common Cold 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Virtual reality training for improving the skills needed for performing surgery of the ear, nose or throat
1. Adult 19-44 years 2. Throat 3. Middle Aged 45-64 years 4. Healthcare Professional 5. Nose 6. Young Adult 19-24 years 7. Ear 8. Otorhinolaryngologic Surgical Procedures
Provide patient population that should be included in the study
Antibiotics for preventing recurrent sore throat
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Sore Throat 6. Middle Aged 45-64 years 7. Disease Recurrence 8. Infant 1 to 23 mo 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Cystic Fibrosis 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Polyps Nasal
Provide patient population that should be included in the study
Pharmacological agents for the prevention of vestibular migraine
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Migrainous Vertigo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Steroid‐eluting sinus stents for improving symptoms in chronic rhinosinusitis patients undergoing functional endoscopic sinus surgery
1. Aged 80 and over 80+ years 2. Child, Preschool 2-5 years 3. Adult 19-44 years 4. Functional Endoscopic Sinus Surgery 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Chronic Rhinosinusitis 8. Aged 65-79 years 9. Polyps Nasal
Provide patient population that should be included in the study
Antibiotics for acute laryngitis in adults
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Acute Laryngitis 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Vestibular rehabilitation for unilateral peripheral vestibular dysfunction
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Dysfunction Of Vestibular System 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Stereotactic radiotherapy for vestibular schwannoma
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Acoustic Neuroma 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Nystagmus 6. Dix-Hallpike Positional Test 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Benign Paroxysmal Positional Vertigo
Provide patient population that should be included in the study
Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Chronic Rhinosinusitis 5. Adolescent 13-18 years 6. Polyps Nasal
Provide patient population that should be included in the study
Over‐the‐counter (OTC) medications for acute cough in children and adults in community settings
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Acute Cough 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgical interventions for chronic rhinosinusitis with nasal polyps
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Rhinosinusitis 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Polyps Nasal